MICHELLE TACKETT: Open Payments
NPI 1851800676 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,473 in 18 payments from 6 companies in 2025. Trend: 2023 $989 · 2024 $488 · 2025 $4,473
Consulting: $2,961Travel & lodging: $807Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $4,046 |
| GENZYME CORPORATION | 4 | $156 |
| Novartis Pharmaceuticals Corporation | 1 | $112 |
| E.R. Squibb & Sons, L.L.C. | 1 | $91 |
| Geron Corporation | 1 | $47 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: SCEMBLIX, REBLOZYL, CABLIVI, RYTELO, WAYRILZ, Cresemba.
Industry payments across FL — which companies pay providers there.
